Latest News and Press Releases
Want to stay updated on the latest news?
-
DALLAS, Sept. 26, 2017 (GLOBE NEWSWIRE) -- TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that Edward Parent has...
-
DALLAS, May 18, 2017 (GLOBE NEWSWIRE) -- TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue...
-
DALLAS, TX--(Marketwired - Mar 22, 2017) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and...
-
DALLAS, TX--(Marketwired - Feb 27, 2017) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that Lisa A....
-
DALLAS, TX--(Marketwired - Mar 28, 2016) - TissueGen® Inc., developer of ELUTE® fiber, controlled, sustained drug delivery from bioresorbable fiber, has been awarded ISO13485:2003...
-
DALLAS, TX--(Marketwired - Dec 15, 2015) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced the...
-
DALLAS, TX--(Marketwired - Dec 1, 2015) - TissueGen® Inc., developer of ELUTE® fiber, groundbreaking biodegradable fiber for delivery of the broadest range of therapeutic drugs, has been...
-
DALLAS, TX--(Marketwired - Jun 23, 2015) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that...
-
DALLAS, TX--(Marketwired - Jan 20, 2015) - TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, closed out 2014 with the...
-
DALLAS, TX--(Marketwired - Nov 13, 2014) - TissueGen® Inc., developer of a groundbreaking biodegradable fiber format for drug delivery, today announced that they will be attending the...